Form 8-K - Current report:
SEC Accession No. 0001279569-22-000614
Filing Date
2022-04-22
Accepted
2022-04-22 17:18:01
Documents
16
Period of Report
2022-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 35544
2 MATERIAL DOCUMENT ex101.htm EX-10.1 17061
3 FORM OF MERGER NOTE ex102.htm EX-10.2 39874
4 NEWS RELEASE DATED MARCH 30, 2022 ex991.htm EX-99.1 86567
5 GRAPHIC logo.jpg GRAPHIC 2281
  Complete submission text file 0001279569-22-000614.txt   387330

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ffnt-20220422.xsd EX-101.SCH 3051
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffnt-20220422_lab.xml EX-101.LAB 34476
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffnt-20220422_pre.xml EX-101.PRE 22607
10 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3410
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 22846699
SIC: 2833 Medicinal Chemicals & Botanical Products